Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of stroke-associated risk alleles in a multi-ethnic Singaporean ischemic stroke cohort.

Scientific reports·2026
Same author

Inflammaging and osteoarthritis - therapeutic opportunities.

Frontiers in immunology·2026
Same author

<i>GCH1</i> p.Ser80Asn Confers Risk for Parkinson's Disease in East Asian Populations.

medRxiv : the preprint server for health sciences·2026
Same author

E3 ubiquitin ligases in neurodegenerative diseases.

Military Medical Research·2026
Same author

A new dawn for Parkinson's disease: commentary on the emergence of stem cell-based therapies.

Translational neurodegeneration·2026
Same author

Ex Vivo LRRK2 Activation in Asian G2385R and R1628P Variant Carriers and Idiopathic Parkinson's Disease.

Movement disorders : official journal of the Movement Disorder Society·2026

Related Experiment Video

Updated: Mar 28, 2026

A cGMP-applicable Expansion Method for Aggregates of Human Neural Stem and Progenitor Cells Derived From Pluripotent Stem Cells or Fetal Brain Tissue
09:37

A cGMP-applicable Expansion Method for Aggregates of Human Neural Stem and Progenitor Cells Derived From Pluripotent Stem Cells or Fetal Brain Tissue

Published on: June 15, 2014

14.3K

Microcarrier-Expanded Neural Progenitor Cells Can Survive, Differentiate, and Innervate Host Neurons Better When

Lifeng Qiu1, Yu Ming Lim, Allen K Chen

  • 1Neural Stem Cell Research Lab, Research Department, National Neuroscience Institute, Singapore.

Cell Transplantation
|January 1, 2016
PubMed
Summary

Transplanting human embryonic stem cell-derived neural progenitor cells (hESC-NPCs) expanded on microcarriers as aggregates improved long-term survival and differentiation in mice, offering a promising cell therapy approach.

More Related Videos

Homochronic Transplantation of Interneuron Precursors into Early Postnatal Mouse Brains
10:08

Homochronic Transplantation of Interneuron Precursors into Early Postnatal Mouse Brains

Published on: June 8, 2018

8.4K
Derivation of Adult Human Fibroblasts and their Direct Conversion into Expandable Neural Progenitor Cells
13:58

Derivation of Adult Human Fibroblasts and their Direct Conversion into Expandable Neural Progenitor Cells

Published on: July 29, 2015

16.2K

Related Experiment Videos

Last Updated: Mar 28, 2026

A cGMP-applicable Expansion Method for Aggregates of Human Neural Stem and Progenitor Cells Derived From Pluripotent Stem Cells or Fetal Brain Tissue
09:37

A cGMP-applicable Expansion Method for Aggregates of Human Neural Stem and Progenitor Cells Derived From Pluripotent Stem Cells or Fetal Brain Tissue

Published on: June 15, 2014

14.3K
Homochronic Transplantation of Interneuron Precursors into Early Postnatal Mouse Brains
10:08

Homochronic Transplantation of Interneuron Precursors into Early Postnatal Mouse Brains

Published on: June 8, 2018

8.4K
Derivation of Adult Human Fibroblasts and their Direct Conversion into Expandable Neural Progenitor Cells
13:58

Derivation of Adult Human Fibroblasts and their Direct Conversion into Expandable Neural Progenitor Cells

Published on: July 29, 2015

16.2K

Area of Science:

  • Stem cell biology
  • Neuroscience
  • Biotechnology

Background:

  • Human embryonic stem cells (hESCs) offer a viable source for neural progenitor cells (NPCs) for transplantation therapies.
  • Traditional monolayer expansion of hESCs into NPCs is time-consuming and yields low cell numbers.
  • Microcarrier (MC) platforms enhance hESC expansion and increase NPC yield.

Purpose of the Study:

  • To evaluate the in vivo survival, differentiation, and innervation of microcarrier-expanded hESC-derived NPCs transplanted as single cells or aggregates.
  • To compare the efficacy of single-cell versus aggregate transplantation of hESC-derived NPCs in a mouse model.

Main Methods:

  • Human embryonic stem cell-derived NPCs were expanded using a microcarrier platform.
  • NPCs were transplanted as single cells or aggregates into the striatum of NOD-SCID IL2Rgc null mice.
  • In vivo survival, differentiation, and innervation were assessed via immunostaining at 1 and 3 months posttransplantation.

Main Results:

  • Both single-cell and aggregate transplants survived for 1 month.
  • Cell aggregates demonstrated superior survival over 3 months compared to single cells.
  • Transplanted NPCs differentiated into immature and mature neurons, with aggregates yielding mature neurons at 3 months.
  • Cell aggregates successfully innervated target regions via long axons.

Conclusions:

  • Microcarrier expansion and aggregate transplantation of hESC-derived NPCs enhance in vivo survival.
  • Transplantation of hESC-derived NPC aggregates shows preclinical promise for cell-based therapies.
  • This approach offers a more efficient method for generating and delivering neural progenitor cells for transplantation.